Ligand · VJM
VJM · 4-(4-{1-[(R)-amino(hydroxy)methyl-lambda~4~-sulfanyl]cyclopropyl}-6-[(3R)-3-methylmorpholin-4-yl]pyrimidin-2-yl)-1H-pyrrolo[2,3-b]pyridine
VJM, 4-(4-{1-[(R)-amino(hydroxy)methyl-lambda~4~-sulfanyl]cyclopropyl}-6-[(3R)-3-methylmorpholin-4-yl]pyrimidin-2-yl)-1H-pyrrolo[2,3-b]pyridine (C20 H26 N6 O2 S, 414.5 g/mol), in the MolNFT structures on GenesisL1: bound in 4 records (2…
- Component
- VJM
- Formula
- C20 H26 N6 O2 S
- Class
- ligand
- Structures
- 4
- PDB entries
- 2
Binding sites
VJM in 4 structures; the first of them:
- 7JSP · Crystal structure of the second bromodomain (BD2) of human TAF1 bound to ATR kinase… · VJM A1701 · binds TRP1526, PRO1527, PHE1528, HIS1530, PRO1531, VAL1532, ASN1533, PHE1536 and 5 more
- 7K03 · Crystal structure of the tandem bromodomain (BD1 and BD2) of human TAF1 bound to ATR… · VJM A1701 · binds TRP1526, PRO1527, PHE1528, HIS1530, PRO1531, VAL1532, ASN1533, PHE1536 and 5 more
- 7JSP · Crystal structure of the second bromodomain (BD2) of human TAF1 bound to atr kinase… · VJM A1701 · binds TRP1526, PRO1527, PHE1528, HIS1530, PRO1531, VAL1532, ASN1533, PHE1536 and 2 more
- 7K03 · Crystal structure of the tandem bromodomain (BD1 and BD2) of human TAF1 bound to atr… · VJM A1701 · binds TRP1526, PRO1527, PHE1528, HIS1530, PRO1531, VAL1532, ASN1533, PHE1536 and 4 more
Residues it binds most
TYR 4, ASN 4, PHE 4, PRO 4, VAL 4, HIS 4, TRP 4 (residue and the binding sites it lines).
Found with
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.